Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-19 5:47 pm Purchase |
2025-03-31 | 13G | VYNE Therapeutics Inc. VYNE |
Cormorant Asset Management LP | 1,849,590 9.990% |
1,849,590 (New Position) |
Filing History |
| 2025-05-19 3:02 pm Sale |
2025-05-15 | 13G | OnKure Therapeutics, Inc. OKUR |
Cormorant Asset Management LP | 0 0.000% |
-1,837,739 (Position Closed) |
Filing History |
| 2025-05-15 3:03 pm Unchanged |
2025-03-31 | 13G | VYNE Therapeutics Inc. VYNE |
Cormorant Asset Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-05-15 3:01 pm Purchase |
2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 1,745,000 8.570% |
51,781 (+3.06%) |
Filing History |
| 2025-05-15 3:00 pm Purchase |
2025-03-31 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
Cormorant Asset Management LP | 3,381,277 7.330% |
3,381,277 (New Position) |
Filing History |
| 2025-02-14 3:03 pm Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 1,693,219 9.080% |
553,219 (+48.53%) |
Filing History |
| 2025-02-14 3:01 pm Purchase |
2024-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Cormorant Asset Management LP | 609,027 9.990% |
609,027 (New Position) |
Filing History |
| 2025-02-14 3:00 pm Purchase |
2024-12-31 | 13G | BioAge Labs, Inc. BIOA |
Cormorant Asset Management LP | 2,629,529 7.340% |
2,629,529 (New Position) |
Filing History |
| 2024-11-14 3:11 pm Purchase |
2024-09-30 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
Cormorant Asset Management LP | 2,940,921 8.040% |
638 (+0.02%) |
Filing History |
| 2024-11-14 3:10 pm Purchase |
2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 2,790,462 8.100% |
648,956 (+30.30%) |
Filing History |
| 2024-11-14 3:10 pm Purchase |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Cormorant Asset Management LP | 8,325,000 12.200% |
2,286,765 (+37.87%) |
Filing History |
| 2024-11-14 3:09 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Cormorant Asset Management LP | 2,375,000 19.500% |
350,000 (+17.28%) |
Filing History |
| 2024-11-14 3:08 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 1,140,000 4.670% |
506,655 (+80.00%) |
Filing History |
| 2024-11-14 3:06 pm Sale |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Cormorant Asset Management LP | 0 0.000% |
-3,670,000 (Position Closed) |
Filing History |
| 2024-11-14 3:05 pm Sale |
2024-09-30 | 13G | TScan Therapeutics, Inc. TCRX |
Cormorant Asset Management LP | 0 0.000% |
-2,500,000 (Position Closed) |
Filing History |
| 2024-11-14 3:05 pm Sale |
2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 500,000 1.310% |
-1,721,422 (-77.49%) |
Filing History |
| 2024-11-14 3:05 pm Sale |
2024-09-30 | 13G | Neurogene Inc. NGNE |
Cormorant Asset Management LP | 107,344 0.830% |
-638,836 (-85.61%) |
Filing History |
| 2024-11-14 3:04 pm Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Cormorant Asset Management LP | 0 0.000% |
-3,250,000 (Position Closed) |
Filing History |
| 2024-11-14 3:04 pm Sale |
2024-09-30 | 13G | Korro Bio, Inc. KRRO |
Cormorant Asset Management LP | 265,826 2.860% |
-263,344 (-49.77%) |
Filing History |
| 2024-11-14 3:03 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 0 0.000% |
-1,700,000 (Position Closed) |
Filing History |